Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Barrett

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
Breast Cancer Research : BCR|March 16, 2012
ER and HER2 expression are positively correlated in HER2 non-overexpressing breast cancerIsabel Pinhel, Margaret Hills, Suzanne Drury, et al.
The Oncologist|August 28, 2010
Epoetin alfa improves anemia and anemia-related, patient-reported outcomes in patients with breast cancer receiving myelotoxic chemotherapy: results of a European, multicenter, randomized, controlled trialPaolo Pronzato, Enrico Cortesi, Carin C van der Rijt, et al.
The Lancet. Oncology|August 23, 2013
Preference for subcutaneous or intravenous administration of trastuzumab in patients with HER2-positive early breast cancer (PrefHer): an open-label randomised studyXavier Pivot, Joseph Gligorov, Volkmar Müller, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|July 16, 2016
An ongoing measles outbreak linked to a suspected imported case, Ireland, April to June 2016Peter Barrett, Katerina Chaintarli, Fiona Ryan, et al.
Science (New York, N.Y.)|April 2, 2016
Antarctic Ice Sheet variability across the Eocene-Oligocene boundary climate transitionSimone Galeotti, Robert DeConto, Timothy Naish, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|November 21, 2021
Mobile Extracorporeal Membrane Oxygenation for Covid-19 Does Not Pose Extra Risk to Transport TeamJeffrey Javidfar, Ahmed Labib, Gabrielle Ragazzo, et al.
The Lancet. Oncology|July 19, 2014
Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trialRobert Coleman, David Cameron, David Dodwell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2007
Human epidermal growth factor receptor 2 status correlates with lymph node involvement in patients with estrogen receptor (ER) negative, but with grade in those with ER-positive early-stage breast cancer suitable for cytotoxic chemotherapyJohn M S Bartlett, Ian O Ellis, Mitch Dowsett, et al.
HRB Open Research|September 14, 2022
Impact of Long COVID on health and quality of lifeLiam O' Mahony, Tanja Buwalda, Matthew Blair, et al.
Journal of the National Cancer Institute|July 22, 2004
Conventional adjuvant chemotherapy versus single-cycle, autograft-supported, high-dose, late-intensification chemotherapy in high-risk breast cancer patients: a randomized trialRobert C F Leonard, Michael Lind, Christopher Twelves, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Breast Cancer Research : BCR|March 16, 2012
ER and HER2 expression are positively correlated in HER2 non-overexpressing breast cancerIsabel Pinhel, Margaret Hills, Suzanne Drury, et al.
The Oncologist|August 28, 2010
Epoetin alfa improves anemia and anemia-related, patient-reported outcomes in patients with breast cancer receiving myelotoxic chemotherapy: results of a European, multicenter, randomized, controlled trialPaolo Pronzato, Enrico Cortesi, Carin C van der Rijt, et al.
The Lancet. Oncology|August 23, 2013
Preference for subcutaneous or intravenous administration of trastuzumab in patients with HER2-positive early breast cancer (PrefHer): an open-label randomised studyXavier Pivot, Joseph Gligorov, Volkmar Müller, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|July 16, 2016
An ongoing measles outbreak linked to a suspected imported case, Ireland, April to June 2016Peter Barrett, Katerina Chaintarli, Fiona Ryan, et al.
Science (New York, N.Y.)|April 2, 2016
Antarctic Ice Sheet variability across the Eocene-Oligocene boundary climate transitionSimone Galeotti, Robert DeConto, Timothy Naish, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|November 21, 2021
Mobile Extracorporeal Membrane Oxygenation for Covid-19 Does Not Pose Extra Risk to Transport TeamJeffrey Javidfar, Ahmed Labib, Gabrielle Ragazzo, et al.
The Lancet. Oncology|July 19, 2014
Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trialRobert Coleman, David Cameron, David Dodwell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2007
Human epidermal growth factor receptor 2 status correlates with lymph node involvement in patients with estrogen receptor (ER) negative, but with grade in those with ER-positive early-stage breast cancer suitable for cytotoxic chemotherapyJohn M S Bartlett, Ian O Ellis, Mitch Dowsett, et al.
HRB Open Research|September 14, 2022
Impact of Long COVID on health and quality of lifeLiam O' Mahony, Tanja Buwalda, Matthew Blair, et al.
Journal of the National Cancer Institute|July 22, 2004
Conventional adjuvant chemotherapy versus single-cycle, autograft-supported, high-dose, late-intensification chemotherapy in high-risk breast cancer patients: a randomized trialRobert C F Leonard, Michael Lind, Christopher Twelves, et al.
Pageof 7